Merrimack Pharmaceuticals Story Overview

MACK -- USA Stock  

USD 5.12  0.01  0.20%

Macroaxis does not monitor all media channels or aggregates social signals for Merrimack Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Merrimack Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Merrimack Pharmaceuticals. Please see also Merrimack Pharmaceuticals Hype Analysis, Merrimack Pharmaceuticals Correlation and Merrimack Pharmaceuticals Performance.
Acquisition by John Mendelsohn of 7500 shares of Merrimack Pharmaceuticals subject to Rule 16b-3
Filed transaction by Merrimack Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3

Merrimack Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by John Mendelsohn, the corporate stakeholder, on December 7, 2017. This event was filed by Merrimack Pharmaceuticals with SEC on 2017-09-15. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on December 7, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.95% . The trading delta at closing time when the story was published against the current closing price is 51.34% .

Similar stores for Merrimack Pharmaceuticals

3 days ago at http://news.cmlviz.com 
Merrimack Pharmaceuticals Inc Risk Points versus Health Care
news
CML NewsFull coverage
over two weeks ago at http://thewellesleysnews.com 
EPS Forecast Revision Trends Merrimack Pharmaceuticals, Inc.
news
Analyst JournalFull coverage
over two weeks ago at http://www.thewellesleysnews.com 
Analyst Stock Ratings Merrimack Pharmaceuticals, Inc. , Air Transport Services Group, Inc.
news
Analyst JournalFull coverage
over three weeks ago at http://hillaryhq.com 
Susquehanna International Group Llp Trimmed Its Autohome Holding Merrimack Pharmaceuticals ...
news
Hillary HQ Full coverage
over a month ago at http://news.cmlviz.com 
Stock Volatility Risk Alert Merrimack Pharmaceuticals Inc Realized Volatility Hits A Towering High
news
CML NewsFull coverage
over a month ago at http://www.schaeffersresearch.com 
2 Pharmaceutical Stocks Touching Record Lows
news
Schaeffers Research Full coverage
over a month ago at http://www.thecoinguild.com 
Investors Will Be Taking a Second Look at Merrimack Pharmaceuticals, Inc. After Recent Moves
news
The Coin GuildFull coverage
over two months ago at http://globalexportlines.com 
Latest figures makes these Stock Even More Attractive HD Supply Holdings, Inc., , Merrimack ...
news
Global Export Lines Going Through the Figures for The Southern Company, , Merrimack Pharmaceuticals, Inc., Nyse Trading News Merrimack Pharmaceuticals, Inc. Reaches 9.16 After 5.00 percent Down Move Last Week HT Group plc LON ... Herald KSFull coverage
over two months ago at http://kgazette.com 
The Navigators Group, Inc. Reaches 61.20 52-Week High 2 Analysts Covering Merrimack Pharmaceuticals ...
news
Key GazetteFull coverage
over two months ago at http://mtastar.com 
Meeder Asset Management Increased JP Morgan Chase Position Advisory Research Has Trimmed Monroe ...
news
MTA StarFull coverage
over two months ago at www.macroaxis.com 
Merrimack Pharmaceuticals exotic insider transaction detected
Macroaxis News
Filed transaction by Merrimack Pharmaceuticals officer. Unconventional Insider trading
over three months ago at http://www.equities.com 
Merrimack Pharmaceuticals Inc. Settles Into New 52-Week Low on March 21 ...
Equities News
Equities.com - Mar 21, 2018 Shares of Merrimack Pharmaceuticals Inc. sank into a new 52-week low yesterday, and could be a company to watch at the open.
over six months ago at http://kldaily.com 
Will Merrimack Pharmaceuticals, Inc. Short Squeeze Soon
news
Merrimack Pharmaceuticals had 10 analyst reports since August 12, 2015 according to SRatingsIntel. Brean Capital maintained Merrimack Pharmaceuticals, Inc. on Tuesday, August 11 with Buy rating. Oppenheimer maintained the stock with ... Somewhat Positive News Coverage Somewhat Unlikely to Impact Merrimack ... - TrueBlueTribune Merrimack Pharmaceuticals, Inc. Ca not Burn Your Short Portfolio. Just ... - Weekly Register

Z Score

Z Score Comparative Analysis
  Z Score 
      Merrimack Pharmaceuticals Comparables 
Merrimack Pharmaceuticals is currently under evaluation in z score category among related companies. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..

Peers

Merrimack Pharmaceuticals Related Equities
EDGE  4.69 %   
0%
36.0%
DNLI  0.73 %   
0%
5.0%
ECYT  0.0303 %   
0%
1.0%
CO  1.33 %   
10.0%
0%
DRNA  1.96 %   
15.0%
0%
DVAX  4.14 %   
31.0%
0%
DOVA  4.49 %   
34.0%
0%
NK  4.94 %   
38.0%
0%
EARS  12.98 %   
100.0%
0%
Please see also Merrimack Pharmaceuticals Hype Analysis, Merrimack Pharmaceuticals Correlation and Merrimack Pharmaceuticals Performance. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.